Skip to content

Giuseppe Bersani

4 papers in the library · 154 citations · publishing 2014-2017

Papers

Sort Most recent Most cited

Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases

Human Psychopharmacology Clinical and Experimental May 1, 2017 Giuseppe Bersani, Elisabeth Prevete 15 citations

OBJECTIVE: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS) and the long-term consequences of NPS use in psychiatric patients. Consequently, it is of the greatest interest to examine which effects NPS can exert in patients with previous severe mental illness (SMI), such as psychotic patients. The aim of this work was a comprehensive review about NPS use...

Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance‐related psychotic symptoms

Human Psychopharmacology Clinical and Experimental July 1, 2015 Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani et al. 41 citations

OBJECTIVE: The pharmacological self-management of novel psychoactive substance (NPS)-induced psychopathological consequences represents a fast growing phenomenon. This is facilitated by the frequent sharing of NPS intake experiences online and by the ease of access to a range of psychotropic medications from both the online and street market. Olanzapine is anecdotally reported by Web users to...

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

BioMed Research International 2014 Francesco Saverio Bersani, Ornella Corazza, Gabriella Albano et al. 98 citations

Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently appeared in the drug market. Methods. A systematic analysis of the scientific literature and a qualitative assessment of online and media...

Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study.

Rivista di psichiatria 2014 Adele Quartini, Annalisa Anastasia, Francesco Saverio Bersani et al.

Sleep disturbances have long been considered as a cardinal symptom of endogenous depression and dreams in depressed patients usually differ from those of healthy people. The aim of the present study was to investigate dream subjective experiences and their modifications in relation to clinical response in a group of escitalopram-treated depressed patients. Twenty-seven female patients meeting...